FIELD: pharmacology.
SUBSTANCE: invention relates to application of 9-phenyl-simm-octahydroseleno-xanthene as a means having an adjuvant effect in radio- and chemotherapy of tumours, and is a compound of the structural formula  (I).
 (I).
EFFECT: decreased negative effects of chemo- and radiotherapy in relation to healthy organs and tissues and increased effect on tumour cells.
1 dwg, 4 ex, 8 tbl
| Title | Year | Author | Number | 
|---|---|---|---|
| SOLUTION THAT HAVE ANTIPROLIFERATIVE AND ANTIMETASTATIC PROPERTIES FOR ONCOLOGICAL DISEASES TREATMENT | 2016 | 
 | RU2678769C2 | 
| AGENT POSSESSING SELECTIVE RADIO- AND CHEMOPROTECTIVE ACTION | 2007 | 
 | RU2339386C1 | 
| HEMATOPOIETIC PRECURSOR CELL DIFFERENTIATION INHIBITOR | 2006 | 
 | RU2317074C1 | 
| METHOD FOR TREATING MALIGNANT NEOPLASMS | 2006 | 
 | RU2320364C1 | 
| COMBINED THERAPY FOR CANCER TREATMENT | 2015 | 
 | RU2708374C2 | 
| USE OF POLYMERIZED HEMOGLOBIN FOR INCREASING EFFICIENCY OF MALIGNANT TUMOR CHEMOTHERAPY | 2021 | 
 | RU2789607C1 | 
| METHOD FOR INCREASING THE EFFECTIVENESS OF IONIZING RADIATION ON MELANOMA | 2021 | 
 | RU2774032C1 | 
| AGENT FOR TREATING FEMALE INFERTILITY AND INFERTILITY OF FEMALE ANIMALS | 2017 | 
 | RU2740922C2 | 
| AGENT WITH ANTITUMOUR AND ANTIMETASTATIC ACTIVITY, ANTI-INFLAMMATORY AND ANTIALLERGIC ACTION | 2018 | 
 | RU2686672C1 | 
| METHOD OF RETARDATION OF MALIGNANT TUMOR GROWTH | 1998 | 
 | RU2143935C1 | 
Authors
Dates
2018-03-05—Published
2015-10-02—Filed